Ardian launches sale of German pharma firm Riemser -sources

14 Mar 2018

FRANKFURT, March 14 (Reuters) – Buyout group Ardian has
launched the sale of German healthcare firm Riemser Pharma,
which may fetch a valuation of more than 400 million euros ($495
million), people close to the matter said.

Read full article at Reuters